Institute of Hygiene and Environmental Medicine, Charité - Universitätsmedizin Berlin, Hindenburgdamm 27, 12203, Berlin, Germany.
Antimicrob Resist Infect Control. 2020 Jul 16;9(1):109. doi: 10.1186/s13756-020-00754-1.
In addition to an overall rise in vancomycin-resistant Enterococcus faecium (VREfm), an increase in certain strain types marked by sequence type (ST) and cluster type (CT) has been reported in Germany over the past few years. Outbreak analyses at Charité - Universitätsmedizin Berlin revealed the frequent occurrence of VREfm ST117 CT71 isolates in 2017 and 2018. To investigate whether ST117 CT71 have emerged in recent years or whether these strains have been circulating for a longer time, we retrospectively analyzed non-outbreak strains that occurred between 2008 and 2018 to identify frequent STs and CTs.
In total, 120 VREfm isolates obtained from clinical and surveillance cultures from the years 2008, 2013, 2015, and 2018 were analyzed. Thirty isolates per year comprising the first 7-8 non-outbreak isolates of each quarter of the respective year were sequenced using whole genome sequencing. MLST and cgMLST were determined as well as resistance genes and virulence factors. Risk factors for VREfm ST117 were analyzed in a multivariable analysis with patient characteristics as possible confounders.
The percentage of VREfm of type ST117 increased from 17% in 2008 to 57% in 2018 (p = 0.012). In 2008, vanA genotype accounted for 80% of all ST117 isolates compared to 6% in 2018. VanB CT71 first appeared in 2018 and predominated over all other ST117 at 43% (p < 0.0001). The set of resistance genes (msrC, efmA, erm(B), dfrG, aac(6')-Ii, gyrA, parC and pbp5) and virulence factors (acm, esp, hylEfm, ecbA and sgrA) in CT71 was also found in other ST117 non-CT71 strains, mainly in CT36. The study population did not differ among the different calendar years analyzed in terms of age, gender, length of stay, or ward type (each p > 0.2).
This study revealed an increase in ST117 strains from 2008 to 2018, accompanied by a shift toward CT71 strains with the vanB genotype in 2018. We did not detect resistance or virulence traits in CT71 that could confer survival advantage compared to other CTs among ST117 strains. To date, it is not clear why ST117 and in particular strain type ST117 CT71 predominates over other strains.
在过去几年中,德国除了肠球菌属粪肠球菌(VREfm)的整体上升外,某些具有序列型(ST)和聚类型(CT)特征的菌株类型也有所增加。柏林夏洛蒂医科大学的暴发分析显示,2017 年和 2018 年频繁出现 VREfm ST117 CT71 分离株。为了研究 ST117 CT71 是否是近年来出现的,或者这些菌株是否已经存在了更长时间,我们回顾性分析了 2008 年至 2018 年间非暴发菌株,以确定常见的 ST 和 CT。
总共分析了 2008 年、2013 年、2015 年和 2018 年从临床和监测培养物中获得的 120 株 VREfm 分离株。每年有 30 株分离株,包括当年每一季度的前 7-8 株非暴发分离株,使用全基因组测序进行测序。确定 MLST 和 cgMLST 以及耐药基因和毒力因子。使用多变量分析分析 VREfm ST117 的危险因素,将患者特征作为可能的混杂因素。
2008 年 ST117 型 VREfm 的比例从 17%上升到 2018 年的 57%(p=0.012)。2008 年,vanA 基因型占所有 ST117 分离株的 80%,而 2018 年为 6%。vanB CT71 于 2018 年首次出现,并以 43%的比例超过所有其他 ST117 (p<0.0001)。CT71 中的耐药基因(msrC、efmA、erm(B)、dfrG、aac(6')-Ii、gyrA、parC 和 pbp5)和毒力因子(acm、esp、hylEfm、ecbA 和 sgrA)也存在于其他 ST117 非 CT71 菌株中,主要存在于 CT36 中。在不同的年份分析中,研究人群在年龄、性别、住院时间或病房类型方面没有差异(每个 p>0.2)。
本研究显示 2008 年至 2018 年间 ST117 菌株增加,2018 年携带 vanB 基因型的 CT71 菌株增加。我们在 CT71 中未检测到与其他 CT 相比赋予 ST117 菌株生存优势的耐药或毒力特征。到目前为止,尚不清楚为什么 ST117 特别是 ST117 CT71 菌株比其他菌株更为普遍。